• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素A对人淋巴细胞体外反应的影响。III. 环孢素A抑制二次混合淋巴细胞反应中T淋巴细胞生长因子的产生,但不抑制致敏淋巴细胞对T细胞生长因子的反应。

Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.

作者信息

Hess A D, Tutschka P J, Santos G W

出版信息

J Immunol. 1982 Jan;128(1):355-9.

PMID:6459374
Abstract

The mechanism whereby Cyclosporin A (CsA) inhibits secondary mixed lymphocyte responses was assessed. CsA added to secondary MLR cultures inhibited proliferation and induction of cytolytic lymphocyte activity. This inhibition was found to be associated with the inhibition of T lymphocyte stimulating growth factor(s) (TCGF) production in the supernatants of secondary MLR cultures. As little as 1.0 micrograms/ml of CsA added to secondary MLR cultures resulted in no measurable TCGF activity. In contrast, moderate doses of CsA (1.0, 2.5 micrograms/ml), which completely inhibited the secondary MLR response to alloantigen, did not inhibit the proliferative and CML response of alloantigen-primed lymphocytes to these stimulating growth factors. Even at high doses of CsA (20 micrograms/ml), substantial levels of proliferation (50% of control response) and CML induction (60% of control response) were observed when the primed cells were exposed to secondary MLR supernatants containing TCGF activity. It was concluded that inhibition of secondary mixed lymphocyte responses by CsA may be due in part to the inhibition of TCGF production rather than the inhibition of the effect of TCGF on mature cytotoxic T lymphocytes.

摘要

评估了环孢菌素A(CsA)抑制二次混合淋巴细胞反应的机制。添加到二次混合淋巴细胞反应(MLR)培养物中的CsA抑制了增殖以及细胞溶解性淋巴细胞活性的诱导。发现这种抑制与二次MLR培养物上清液中T淋巴细胞刺激生长因子(TCGF)产生的抑制有关。向二次MLR培养物中添加低至1.0微克/毫升的CsA会导致无法检测到TCGF活性。相反,中等剂量的CsA(1.0、2.5微克/毫升)完全抑制了对同种异体抗原的二次MLR反应,但并未抑制同种异体抗原致敏淋巴细胞对这些刺激生长因子的增殖反应和细胞介导的淋巴细胞溶解(CML)反应。即使在高剂量的CsA(20微克/毫升)下,当致敏细胞暴露于含有TCGF活性的二次MLR上清液时,仍观察到大量的增殖(对照反应的50%)和CML诱导(对照反应的60%)。得出的结论是,CsA对二次混合淋巴细胞反应的抑制可能部分归因于对TCGF产生的抑制,而不是对TCGF对成熟细胞毒性T淋巴细胞作用的抑制。

相似文献

1
Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.环孢素A对人淋巴细胞体外反应的影响。III. 环孢素A抑制二次混合淋巴细胞反应中T淋巴细胞生长因子的产生,但不抑制致敏淋巴细胞对T细胞生长因子的反应。
J Immunol. 1982 Jan;128(1):355-9.
2
Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.环孢素A对人淋巴细胞体外反应的影响。I. 环孢素A允许同种异体抗原激活的抑制细胞表达,同时在混合淋巴细胞反应中优先抑制细胞溶解效应淋巴细胞的诱导。
J Immunol. 1980 Jun;124(6):2601-8.
3
Development of precytotoxic T cells in cyclosporine-suppressed mixed lymphocyte reactions.环孢素抑制的混合淋巴细胞反应中细胞毒性前体T细胞的发育
J Immunol. 1990 Feb 1;144(3):816-23.
4
Effect of cyclosporin A on human lymphocyte responses in vitro. IV. Production of T cell stimulatory growth factors and development of responsiveness to these growth factors in CsA-treated primary MLR cultures.环孢素A对人淋巴细胞体外反应的影响。IV. CsA处理的原代混合淋巴细胞反应培养物中T细胞刺激生长因子的产生以及对这些生长因子反应性的发展。
J Immunol. 1982 Jan;128(1):360-7.
5
Analysis of cloned T cell function. I. Dissection of cloned T cell proliferative responses using cyclosporin A.克隆化T细胞功能分析。I. 使用环孢菌素A剖析克隆化T细胞的增殖反应。
J Immunol. 1982 Nov;129(5):1865-8.
6
Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.环孢菌素A不能阻止Tac抗原(一种可能的TCGF受体分子)在有丝分裂原刺激的人T细胞上表达。
J Immunol. 1983 Jun;130(6):2737-42.
7
Effects of anti-interleukin-2 receptor antibody and cyclosporin A on human T cell proliferation in primary mixed lymphocyte reaction.抗白细胞介素-2受体抗体和环孢素A对原发性混合淋巴细胞反应中人类T细胞增殖的影响。
Hiroshima J Med Sci. 1989 Mar;38(1):1-6.
8
Human cytotoxic T lymphocytes. II. Frequency analysis of cyclosporin A-sensitive alloreactive cytotoxic T-lymphocyte precursors.人细胞毒性T淋巴细胞。II. 环孢菌素A敏感的同种异体反应性细胞毒性T淋巴细胞前体的频率分析。
Immunology. 1987 May;61(1):57-62.
9
Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
Transplantation. 1985 Jan;39(1):62-8. doi: 10.1097/00007890-198501000-00007.
10
Cyclosporin A inhibits IL 2-driven proliferation of human alloactivated T cells.环孢菌素A抑制白细胞介素2驱动的人同种异体活化T细胞的增殖。
J Immunol. 1986 Jun 1;136(11):4035-9.

引用本文的文献

1
A real-world disproportionality analysis of cyclosporine from the FDA Adverse Event Reporting System (FAERS) database.基于 FDA 不良事件报告系统(FAERS)数据库的环孢素真实世界药物不良反应比例分析。
Braz J Med Biol Res. 2024 Jul 29;57:e13392. doi: 10.1590/1414-431X2024e13392. eCollection 2024.
2
Comparative tolerability of therapies for ulcerative colitis.溃疡性结肠炎治疗方法的耐受性比较
Drug Saf. 2002;25(8):561-82. doi: 10.2165/00002018-200225080-00003.
3
Comparative tolerability of treatments for inflammatory bowel disease.炎症性肠病治疗方法的耐受性比较
Drug Saf. 2000 Nov;23(5):429-48. doi: 10.2165/00002018-200023050-00006.
4
A practical guide to the management of distal ulcerative colitis.远端溃疡性结肠炎管理实用指南
Drugs. 1998 Apr;55(4):519-42. doi: 10.2165/00003495-199855040-00004.
5
Complete prevention of the clinical expression of adjuvant-induced arthritis in rats by cyclosporin-A and lobenzarit: the regulation of lymph node cell populations and cytokine production.环孢素A和氯苯扎利完全预防大鼠佐剂性关节炎的临床症状:淋巴结细胞群体和细胞因子产生的调节
Inflamm Res. 1996 Apr;45(4):159-65. doi: 10.1007/BF02285155.
6
The clinical and immunological effects of cyclosporin A on patients with rheumatoid arthritis.环孢素A对类风湿关节炎患者的临床及免疫学影响。
Clin Rheumatol. 1995 Sep;14(5):537-43. doi: 10.1007/BF02208151.
7
Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin.用环孢素治疗相关原发性硬化性胆管炎后溃疡性结肠炎的疾病活动情况。
Gut. 1993 Feb;34(2):242-6. doi: 10.1136/gut.34.2.242.
8
Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.环孢素。对其药效学和药代动力学特性以及在免疫调节紊乱中的治疗应用的综述。
Drugs. 1993 Jun;45(6):953-1040. doi: 10.2165/00003495-199345060-00007.
9
Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives.吩噻嗪衍生物对环孢菌素A/ FK506耐药的、淋巴因子诱导的T细胞活化的抑制作用
Naunyn Schmiedebergs Arch Pharmacol. 1994 Jul;350(1):100-3. doi: 10.1007/BF00180018.
10
Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse.环孢菌素A对小鼠迟发型超敏反应和淋巴因子产生的抑制作用。
Clin Exp Immunol. 1983 Jun;52(3):599-606.